MSD petitions SCOTUS over $2.5bn patent verdict
28-09-2020
Brazil accuses Gilead over 1,421.5% price hike of hep C drug
24-10-2019
Fed Circuit sides with Merck in antifungal treatment dispute
25-06-2019
eyesonmilan / Shutterstock.com
The US Court of Appeals for the Federal Circuit has delivered a blow for Merck in a patent infringement dispute against Gilead, upholding one of its patents as invalid.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Merck, Gilead, hepatitis C, patent infringement, patent validity, US Court of Appeals for the Federal Circuit
